Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent

Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent

US Patent 9511139 · Granted Dec 6, 2016

Estimated economic value: $5,046,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treatment of cancer2022
Therapeutic combination and methods of treatment with a DLL4 antagonist and an a2020
Therapeutic combination and methods of treatment with a DLL4 antagonist and an a2020
Methods and monitoring of treatment with a WNT pathway inhibitor2018
Therapeutic combination and methods of treatment with a DLL4 antagonist and an a2018
Therapeutic combination and methods of treatment with a DLL4 antagonist and an a2018
Methods and monitoring of treatment with a DLL4 antagonist2017
Methods and monitoring of treatment with a DLL4 antagonist2017
Methods and monitoring of treatment with a Wnt pathway inhibitor2016
Methods of treating neuroendocrine tumors using frizzled-binding agents2016
Methods of treatment with DLL4 antagonists and an anti-hypertensive agent2014
Methods of treatment with DLL4 antagonists and an anti-hypertensive agent2014